Rewired type I IFN signaling is linked to age-dependent differences in COVID-19
Authors
- Lev Petrov
- Sophia Brumhard
- Sebastian Wisniewski
- Philipp Georg
- David Hillus
- Anna Hiller
- Rosario Astaburuaga-García
- Nils Blüthgen
- Emanuel Wyler
- Katrin Vogt
- Hannah-Philine Dey
- Saskia von Stillfried
- Christina Iwert
- Roman D. Bülow
- Bruno Märkl
- Lukas Maas
- Christine Langner
- Tim Meyer
- Jennifer Loske
- Roland Eils
- Irina Lehmann
- Benjamin Ondruschka
- Markus Ralser
- Jakob Trimpert
- Peter Boor
- Sammy Bedoui
- Christian Meisel
- Marcus A. Mall
- Victor M. Corman
- Leif Erik Sander
- Jobst Röhmel
- Birgit Sawitzki
Journal
- Cell Reports Medicine
Citation
- Cell Rep Med 6 (8): 102285
Abstract
Advanced age is the most important risk factor for severe disease or death from COVID-19, but a thorough mechanistic understanding of the molecular and cellular underpinnings is lacking. Multi-omics analysis of 164 samples from SARS-CoV-2-infected persons aged 1 to 84 years reveals a rewiring of type I interferon (IFN) signaling with a gradual shift from signal transducer and activator of transcription 1 (STAT1) to STAT3 activation in monocytes, CD4(+) T cells, and B cells with increasing age. Diversion of IFN signaling is associated with increased expression of inflammatory markers, enhanced release of inflammatory cytokines, and delayed contraction of infection-induced CD4(+) T cells. A shift from IFN-responsive germinal center B (GCB) cells toward CD69(high) GCB and atypical B cells during aging correlates with immunoglobulin (Ig)A production in children, whereas complement-fixing IgG predominates in adults. Our data provide a mechanistic basis for inflammation-prone responses to infections and associated pathology during aging.